Antibodies are studied more than other immune proteins for association with disease. This does not mean that they are more decisive in disease outcomes. Type I interferon likely has far more impact.
Antibodies Are Not the Whole Story of Immune Resilience Toward Cancer
This post was created with our nice and easy submission form. Create your post!
Comments
Loading…